Topical Treatment of Elevated Intraocular Pressure in Patients with Graves' Orbitopathy.

: In this study, we evaluated the efficacy of topical hypotensive treatment and/or systemic corticosteroids therapy in patients with elevated intraocular pressure and Graves' orbitopathy (GO). : We included 172 eyes in 86 individuals with duration of GO ≥ 3 months, intraocular pressure in either eye ≥ 25.0 mmHg, and GO ranked ≥ 3 at least in one eye in modified CAS form.

Latanoprost is effective in reducing high intraocular pressure associated with Graves' ophthalmopathy.

Purpose: To assess the efficacy and tolerability of latanoprost in the treatment of glaucoma and ocular hypertension associated with Graves' ophthalmopathy. Prospective interventional case series.

Materials And Methods: 28 patients (19 females and 9 males) aged from 31 to 68 (mean age 45.